Moderna and Merck Melanoma Vaccine Wins Phase 3. Regulators Are the Next Test
The Moderna Merck melanoma vaccine met its Phase 3 goals. What regulators will weigh next, and what the companies have not yet said.
Tag: intismeran autogene
Read More